{"slideshow_credits": null, "snippet": "A merger would create a drug giant with nearly $53 billion in annual sales and give Pfizer a long-sought foreign headquarters for tax purposes.", "abstract": "Pfizer is near agreement to buy rival drug maker Allergan for up to $150 billion.", "section_name": "Business Day", "print_page": "6", "document_type": "article", "byline": {"person": [{"lastname": "de la MERCED", "rank": 1, "firstname": "Michael", "role": "reported", "organization": "", "middlename": "J."}], "original": "By MICHAEL J. de la MERCED", "contributor": "Liz Moyer contributed reporting."}, "web_url": "http://www.nytimes.com/2015/11/19/business/dealbook/pfizer-allergan-deal-for-up-to-150-billion-is-said-to-be-close-to-complete.html", "lead_paragraph": "A merger would create a drug giant with nearly $53 billion in annual sales and give Pfizer a long-sought foreign headquarters for tax purposes.", "headline": {"main": "Pfizer and Allergan Said to Be Near Merger for Up to $150 Billion", "print_headline": "Pfizer and Allergan Said to Be Close to $150 Billion Merger"}, "_id": "564d2aff38f0d81eb3ced09c", "word_count": "580", "multimedia": [{"height": 126, "url": "images/2015/11/20/business/db-drug-web1/db-drug-web1-thumbWide.jpg", "legacy": {"wideheight": "126", "wide": "images/2015/11/20/business/db-drug-web1/db-drug-web1-thumbWide.jpg", "widewidth": "190"}, "subtype": "wide", "width": 190, "type": "image"}, {"height": 400, "url": "images/2015/11/20/business/db-drug-web1/db-drug-web1-articleLarge.jpg", "legacy": {"xlarge": "images/2015/11/20/business/db-drug-web1/db-drug-web1-articleLarge.jpg", "xlargewidth": "600", "xlargeheight": "400"}, "subtype": "xlarge", "width": 600, "type": "image"}, {"height": 75, "url": "images/2015/11/20/business/db-drug-web1/db-drug-web1-thumbStandard.jpg", "legacy": {"thumbnail": "images/2015/11/20/business/db-drug-web1/db-drug-web1-thumbStandard.jpg", "thumbnailwidth": "75", "thumbnailheight": "75"}, "subtype": "thumbnail", "width": 75, "type": "image"}], "pub_date": "2015-11-19T00:00:00Z", "source": "The New York Times", "news_desk": "Business", "keywords": [{"name": "organizations", "value": "Allergan Inc", "is_major": "Y", "rank": "1"}, {"name": "organizations", "value": "Pfizer Inc", "is_major": "Y", "rank": "2"}, {"name": "subject", "value": "Mergers, Acquisitions and Divestitures", "is_major": "N", "rank": "3"}, {"name": "subject", "value": "Tax Shelters", "is_major": "N", "rank": "4"}, {"name": "subject", "value": "Corporate Taxes", "is_major": "N", "rank": "5"}, {"name": "subject", "value": "Drugs (Pharmaceuticals)", "is_major": "N", "rank": "6"}], "blog": [], "subsection_name": "DealBook", "type_of_material": "News"}